High-Throughput Screening (HTS)

The cornerstone of modern drug discovery, enabling rapid identification of potential therapeutic candidates from vast compound libraries. At WaveCyte BioLabs, we leverage cutting-edge automation and advanced assay technologies to deliver precise, high-quality data that accelerates your research pipeline and drug discovery.

Our HTS Services

Compound Library Screening: Evaluation of extensive libraries to identify lead compounds with desired biological activity.

Target Validation Studies: Assays focused on specific molecular targets, such as enzymes, receptors, or signaling pathways. Primary Hits are confirmed and further characterized with additional assays to assess specificity and potency

Phenotypic Screening: Cell-based assays to evaluate compound effects on complex biological systems.

Cytotoxicity & Safety Profiling: Early assessment of compound toxicity and safety using cell viability and functional assays.

What Is High-Throughput Screening (HTS)

HTS is a crucial technique in drug discovery that leverages automation to rapidly test vast libraries of compounds against specific biological targets. This process incorporates robotic systems and sophisticated data analysis to identify "hits" or drug candidates that exhibit desired biological activity.

Applying HTS to accelerate drug discovery by enabling rapid, large-scale testing. Using automation-enabled systems, we provide target validation studies and assay optimization. These services are ideal for identifying potential drug candidates efficiently.

Find out how we can help